Advertisement
Screener

OPTIMER PHARMACEUTICALS INC Selling, General and Administrative Expense

OPTIMER PHARMACEUTICALS INC Selling, General and Administrative Expense

OPTIMER PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $30.52 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2013-08-07

  • OPTIMER PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2013-06-30 was $30.52M, a 5.77% increase year-over-year.
  • OPTIMER PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2013-03-31 was $34.00M, a 33.22% increase year-over-year.
  • OPTIMER PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-12-31 was $31.20M, a 4.04% increase year-over-year.
  • OPTIMER PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-09-30 was $26.44M, a 10.11% increase year-over-year.
  • OPTIMER PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2012 was $112.03M, a 39.03% increase from fiscal 2011.
  • OPTIMER PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2011 was $80.57M, a 359.09% increase from fiscal 2010.
  • OPTIMER PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2010 was $17.55M, a 93.42% increase from fiscal 2009.
  • OPTIMER PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2009 was $9.07M.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 3 month as first filedSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 9 month as first filedSelling, General and Administrative Expense 12 monthSelling, General and Administrative Expense 12 month as first filed
2013-06-30$30.52M
10-Q · filed 2013-08-07
$64.52M
10-Q · filed 2013-08-07
$95.72M
derived: sum of 3 quarters · filed 2013-08-07
$122.17M
derived: sum of 4 quarters · filed 2013-08-07
2013-03-31$34.00M
10-Q · filed 2013-05-10
$65.20M
derived: sum of 2 quarters · filed 2013-05-10
$91.65M
derived: sum of 3 quarters · filed 2013-05-10
$120.50M
derived: sum of 4 quarters · filed 2013-08-07
2012-12-31$31.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$57.65M
derived: sum of 2 quarters · filed 2013-03-18
$86.50M
derived: sum of 3 quarters · filed 2013-08-07
$112.03M
10-K · filed 2013-03-18
2012-09-30$26.44M
10-Q · filed 2012-11-02
$55.30M
derived: sum of 2 quarters · filed 2013-08-07
$80.82M
10-Q · filed 2012-11-02
$110.82M
derived: sum of 4 quarters · filed 2013-08-07
2012-06-30$28.86M
10-Q · filed 2013-08-07
$54.38M
10-Q · filed 2013-08-07
$84.37M
derived: sum of 3 quarters · filed 2013-08-07
$108.39M
derived: sum of 4 quarters · filed 2013-08-07
2012-03-31$25.52M
10-Q · filed 2013-05-10
$55.51M
derived: sum of 2 quarters · filed 2013-05-10
$79.53M
derived: sum of 3 quarters · filed 2013-05-10
$94.29M
derived: sum of 4 quarters · filed 2013-05-10
2011-12-31$29.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$54.01M
derived: sum of 2 quarters · filed 2013-03-18
$68.77M
derived: sum of 3 quarters · filed 2013-03-18
$80.57M
10-K · filed 2013-03-18
$87.14M
10-K · filed 2012-03-08
2011-09-30$24.02M
10-Q · filed 2012-11-02
$26.94M
10-Q · filed 2011-11-03
$38.78M
derived: sum of 2 quarters · filed 2012-11-02
$50.58M
10-Q · filed 2012-11-02
$53.51M
10-Q · filed 2011-11-03
$56.29M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$14.76M
10-Q · filed 2012-08-03
$26.57M
10-Q · filed 2012-08-03
$32.27M
derived: sum of 3 quarters · filed 2013-03-18
$37.12M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$11.81M
10-Q · filed 2012-05-10
$17.51M
derived: sum of 2 quarters · filed 2013-03-18
$22.36M
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$5.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$10.55M
derived: sum of 2 quarters · filed 2013-03-18
$17.55M
10-K · filed 2013-03-18
2010-09-30$4.84M
10-Q · filed 2011-11-03
$11.84M
10-Q · filed 2011-11-03
2009-12-31$9.07M
10-K · filed 2012-03-08